Quantum sensors for magnetic measurements - 02/06/2026 New insights into muscle physiology – contactless and three-dimensional Contactless measurement of muscle activity and training effects: using highly sensitive quantum sensors, researchers at the Universities of Tübingen and Stuttgart are setting new standards. This technology has the potential to revolutionise clinical diagnostics and optimise training and neuroscience research.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-insights-muscle-physiology-contactless-and-three-dimensional
Press release - 01/06/2026 Central Institute of Mental Health joins international Lancet Commission on schizophrenia Leading scientists are pooling their expertise to further advance research and care for psychotic disorders and to align them more closely with the needs of affected individuals. https://www.gesundheitsindustrie-bw.de/en/article/press-release/central-institute-mental-health-joins-international-lancet-commission-schizophrenia
Press release - 29/05/2026 FCI Supports Teaching Concept for the Chemistry of Tomorrow The German Chemical Industry Fund (FCI) is supporting the course offering ‘DigiChemJN’ at the Faculty of Chemistry and Pharmacy. DigiChemJN strengthens students’ data literacy by providing them qualifications in data-based research methods, experimental datasets, and artificial intelligence (AI).https://www.gesundheitsindustrie-bw.de/en/article/press-release/fci-supports-teaching-concept-chemistry-tomorrow
Press release - 28/05/2026 An immune defence guide Which cellular processes ensure that immune responses are controlled precisely? A new study by the Institute of Cell Biology and Immunology Thurgau (BITG) and the University of Konstanz decodes a decisive signalling pathway.https://www.gesundheitsindustrie-bw.de/en/article/press-release/immune-defence-guide
Press release - 27/05/2026 New Emmy Noether Junior Research group investigates the mode of action of Antimetabolite Chemotherapy How do antimetabolite cancer drugs damage the genetic material of malignantly transformed cells and thereby destroy them? How might these drugs be used more precisely, particularly in the treatment of pediatric tumors? A new research group led by Dr. Christopher Carnie, a scientist at the Heidelberg Faculty of Medicine at Heidelberg University, will address these questions. https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-emmy-noether-junior-research-group-investigates-mode-action-antimetabolite-chemotherapy
Press release - 27/05/2026 Funding for three Collaborative Research Centres at DZHK sites The German Research Foundation (DFG) is establishing new Collaborative Research Centres and extending existing research networks. Several DZHK sites are also involved. Particular emphasis is being placed on new research approaches to inflammation and thrombosis.https://www.gesundheitsindustrie-bw.de/en/article/press-release/Funding-for-three-Collaborative-Research-Centres-at-DZHK-sites
Press release - 26/05/2026 Heidelberg based development revolutionizes hepatitis D therapy worldwide: US Food and Drug Administration (FDA) approves hepatitis drug Hepcludex (bulevirtide) Joint press release of the Heidelberg Faculty of Medicine at Heidelberg University and the German Center for Infection Research: With the FDA approval of Hepcludex (bulevirtide), a therapy for chronic hepatitis D developed at the Heidelberg Faculty of Medicine at Heidelberg University, Heidelberg University Hospital, and the German Center for Infection Research (DZIF) has now reached the world’s most important pharmaceutical market.https://www.gesundheitsindustrie-bw.de/en/article/press-release/heidelberg-based-development-revolutionizes-hepatitis-d-therapy-worldwide-us-food-and-drug-administration-fda-approves-hepatitis